Cited by 65HIV Research and TreatmentCellular transport and secretionVirus-based gene therapy research

Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production

Open access
Meng, Bo, Ip, Natasha C Y, Prestwood, Liam J, Abbink, Truus E M, Lever, Andrew M L·2015·Retrovirology

Abstract

BACKGROUND: Egress of a number of different virus species from infected cells depends on proteins of the endosomal sorting complexes required for transport (ESCRT) pathway. HIV has also hijacked this system to bud viruses outward from the cell surface. How ESCRT-I activates ESCRT-III in this process remains unclear with conflicting published evidence for the requirement of ESCRT-II which fulfils this role in other systems. We investigated the role of ESCRT-II using knockdown mediated by siRNA and shRNA, mutants which prevent ESCRT-I/ESCRT-II interaction and a CRISPR/Cas9 EAP45 knockout cell line. RESULTS: Depletion or elimination of ESCRT-II components from an HIV infected cell produces two distinct effects. The overall production of HIV-1 Gag is reduced leading to a diminished amount of intracellular virion protein. In addition depletion of ESCRT-II produces an effect similar to that seen when ESCRT-I and -III components are depleted, that of a delayed Gag p26 to p24 +p2 cleavage associated with a reduction in export of virion particles and a visible reduction in budding efficiency in virus producing cells. Mutants that interfere with ESCRT-I interacting with ESCRT-II similarly reduce virus export. The export defect is independent of the decrease in overall Gag production. Using a mutant virus which cannot use the ALIX mediated export pathway exacerbates the decrease in virus export seen when ESCRT-II is depleted. ESCRT-II knockdown does not lead to complete elimination of virus release suggesting that the late domain role of ESCRT-II is required for optimal efficiency of viral budding but that there are additional pathways that the virus can employ to facilitate this. CONCLUSION: ESCRT-II contributes to efficient HIV virion production and export by more than one pathway; both by a transcriptional or post transcriptional mechanism and also by facilitating efficient virus export from the cell through interactions with other ESCRT components.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12977-015-0197-x

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Loss of ALIX recruitment to viral budding sites or cytokinetic bridges impairs but does not terminate these events.

    “the loss of ALIX recruitment to viral budding sites through HIV L domain deletion or to cytokinetic bridges via cellular depletion by RNA interference (RNAi) impairs but does not terminate these events.”

    From Budding of a Retrovirus: Some Assemblies Required (2020) · cites this paper as [18]

    The Background identifies the YPXL motif as the route by which HIV-1 Gag recruits ALIX, and the Results (‘Knockdown of ESCRT-II has an additive effect on release of YPXL mutant virus’; page unavailable) report reduced, rather than abolished, virion export after YPXL mutation. Our copy does not report ALIX depletion by RNAi at cytokinetic bridges or its effect on cytokinesis; its discussion of cytokinesis concerns ESCRT-II. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Redundant and parallel ESCRT-III recruiting axes are mandated.

    “This mandates the presence of redundant and parallel ESCRT-III recruiting axes perhaps fulfilled by the intermediary ESCRT-II complex [13,17,18] or additional ALIX homologs and orthologs [19,20,21].”

    From Budding of a Retrovirus: Some Assemblies Required (2020) · cites this paper as [18]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Meng, B., Ip, N. C. Y., Prestwood, L. J., Abbink, T. E. M., & Lever, A. M. L.
Affiliations
University of Cambridge (GB)
Corresponding author
Lever, Andrew M L
Venue
Retrovirology
Published
2015-08-14
Volume
12
Issue
1
Pages
72-72
ISSN
1742-4690 (ISSN-L)
OpenAlex
W2147257015
Cited by
65
References
52
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 12 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 7 · 2015: 1
FWCI
3.88
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Retrovirology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • National University of Singapore (submittedVersion, cc-by)
  • VU Research Portal (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • University of Cambridge Clinical School MB/PhD Programme, Frank Edward Elmore Fund and James Baird Fund, Magdalene College Leslie Wilson Minor Award, and Overseas Research Students Awards Scheme (RCAG/032)
  • Medical Research Council (RCAG/269)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
ESCRT-II, HIV-1, viral budding, late domain, Gag processing, Alix, ESCRT-I, ESCRT-III
MeSH terms
Biological Transport, Cell Line, Humans, Mutation, Protein Binding, Virion, HIV-1, Protein Structure, Tertiary, RNA, Small Interfering, gag Gene Products, Human Immunodeficiency Virus, Gene Knockout Techniques, Endosomal Sorting Complexes Required for Transport, Virus Release, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review